Yahoo
    Paris - Delayed Quote EUR

    AB Science S.A. (AB.PA)

    Get top stock picks
    0.7175 -0.0145 (-2.00%)
    As of 9:28:00 AM GMT+2. Market Open.
    Get top stock picks
    Loading Chart for AB.PA
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026

    AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026
    GlobeNewswire 21d ago
    AB Science announces today the successful completion of capital increases of a total gross amount of EUR 14.2 million

    AB Science announces today the successful completion of capital increases of a total gross amount of EUR 14.2 million
    GlobeNewswire 28d ago
    AB Science patent for masitinib in the treatment of metastatic castrate resistant prostate cancer formally granted in the United States with a protection until 2042

    AB Science patent for masitinib in the treatment of metastatic castrate resistant prostate cancer formally granted in the United States with a protection until 2042
    GlobeNewswire 2mo ago
    AB Science provides an update on its clinical development program.

    AB Science provides an update on its clinical development program.
    GlobeNewswire 4mo ago
    AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs

    AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs
    GlobeNewswire 1mo ago
    AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share

    AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share
    GlobeNewswire 3mo ago
    AB Science announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors

    AB Science announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors
    GlobeNewswire 4mo ago
    AB Science announces the successful completion of a EUR 2.3 million private placement

    AB Science announces the successful completion of a EUR 2.3 million private placement
    GlobeNewswire 2mo ago
    AB Science reports its revenues for the year 2025 and provides an update on its activities

    AB Science reports its revenues for the year 2025 and provides an update on its activities
    GlobeNewswire 3mo ago
    The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight

    The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
    PR Newswire 1mo ago
    Masitinib Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

    Masitinib Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
    GlobeNewswire 3mo ago

    Related Tickers

    HKMPY
    STX.L
    EVT.DE
    MRK.DE
    SDZNY
    AMLX
    ALVO
    LNTH
    CGC
    HIMS
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: